PhaseV and Quanticate partner to help sponsors run more adaptive trials
PhaseV has partnered with contract research organization (CRO) Quanticate to improve the speed and quality of clinical development programs to…
PhaseV has partnered with contract research organization (CRO) Quanticate to improve the speed and quality of clinical development programs to…
Paris-based Exeliom Biosciences will focus Phase III efforts of its immune modulating drug EXL01 in gastric cancer if it succeeds…
EXO Biologics is hoping to receive conditional market approval from the European Medicines Agency (EMA) for its bronchopulmonary dysplasia (BPD)…
California-based Regeneration Biomedical has dosed the first patient has been dosed in a first-in-human trial of its autologous stem cell…
Keeping track of your pulse, heart rate and oxygen saturation has never been easier, with smartwatches able to easily track…
Inozyme Pharma is speaking to the US Food and Drug Administration (FDA) about running a Phase III trial of INZ-701…
Technology has propelled advancements in the clinical trial landscape, with investigators utilising artificial intelligence (AI) and machine learning (ML) in…
Chinese-based Joincare Pharmaceutical has met the primary endpoint in a Phase III trial of its partnered flu candidate TG-1000. Taiwan-based…
Pulmocide has announced evidence of prevention of pulmonary aspergillosis with pipeline candidate opelconazole after releasing topline data from a Phase…
Lyon, France-based MaaT Pharma has announced positive 18-month data for its lead candidate MaaT013 showing an overall survival advantage in…